Company intelligence / Profile preview

Theialife Sciences

Dubai, Dubai, United Arab Emiratestheialife.com ↗
Ownership
Private
Development stage
Phase 3
01

Overview

Theialife's lead program ND10/7MX is the world's first clinical phase III-ready oral therapy for pediatric myopia. It has completed preclinical and phase II trials with over a decade of real-world use in Denmark (~1200 children treated), showing safety and efficacy with no reported adverse effects. Data published in the British Journal of Ophthalmology supports its effectiveness in children aged 6–11 at risk of high myopia progression. Global phase III trials are set to begin soon.

Therapeutic areas
Ophthalmology
Modalities
Small molecules (notably oral therapeutics)Extended-release formulationsNovel molecular platforms for ophthalmic diseases
Industry
Biotech
02

Drug pipeline

3 assets

rHCT3-2

Preclinical

2 more assets in the full pipeline.

Request access →
03

Partnerships

Open to collaborations with biotech/pharma partners globally for co-development/licensing/commercialization but no specific major partnerships disclosed yet.

Beyond the preview

Go deeper on Theialife Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theialife Sciences.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call